Nayiri M Kaissarian, Nigam Padhiar, Nathan Clement, Wells W Wu, Upendra Katneni, Anton A Komar, Chava Kimchi-Sarfaty
Accurate measurement of therapeutic protein concentration is critical for ensuring manufacturing consistency. Synonymous gene recoding is often used to improve protein yield, including for coagulation Factor IX (FIX), used to treat Hemophilia B. Although synonymous recoding does not alter primary amino acid sequence, it can affect protein conformation, potentially influencing the accuracy of protein quantification depending on the method used. In this study, we investigated whether synonymous changes in F9 gene, which encodes FIX, impacted reliability of commonly used protein quantitation methods. HEK293- FlpIn cells were used to generate FIX proteins expressed from seven different synonymous F9 sequences. Purified proteins were initially measured using absorbance at 280 nm, followed by quantification using various colorimetric, and fluorometric protein assays. Relative differences among protein quantification methods were inconsistent between wild-type and synonymous F9 variants. Compared with A280 measurements, mean differences across variants ranged from - 33% to - 8% for Bradford and from 14 to 54% for BCA, whereas wider ranges were observed for OPA (- 23% to 133%), CBQCA (14% to 282%), and Lowry (1% to 185%). Bradford and BCA also exhibited lower intra-assay variability, with standard deviations of 6% and 10%, respectively, compared with 12%, 18%, and 33% for OPA, CBQCA, and Lowry assays. These findings indicate that synonymous codon substitutions influence protein quantification outcomes, with Bradford and BCA producing more consistent results and lowest variability, whereas amine-reactive fluorescence-based assays (OPA and CBQCA) showed greater inconsistencies. In conclusion, protein quantification methods may not produce consistent accuracy among proteins translated from synonymously recoded sequences.